Unicycive Therapeutics, Inc. logo

Unicycive Therapeutics, Inc.

NASDAQ:UNCY

Overview | Financials
Company Name Unicycive Therapeutics, Inc.
Symbol UNCY
Currency USD
Price 0.435
Market Cap 41,016,640
Dividend Yield 0%
52-week-range 0.202 - 1.818
Industry Biotechnology
Sector Healthcare
CEO Dr. Shalabh K. Gupta M.D., MPA
Website https://www.unicycive.com

An error occurred while fetching data.

About Unicycive Therapeutics, Inc.

Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based

Related Stocks

NeuroBo Pharmaceuticals, Inc. logo

NeuroBo Pharmaceuticals, Inc.

NRBO

2.92 USD

Rockwell Medical, Inc. logo

Rockwell Medical, Inc.

RMTI

3.475 USD

Cyclacel Pharmaceuticals, Inc. logo

Cyclacel Pharmaceuticals, Inc.

CYCCP

11.81 USD

Financials

Numbers are in millions USD

Numbers are in millions USD